The Carlyle Group has made a partial exit from India-listed life insurance company SBI Life, selling one-third of its stake for approximately INR28.2 billion ($392 million).
The private equity firm offloaded 30 million shares for INR938.83 apiece, according to stock exchange data. The stock has performed strongly since March, gaining more than 70%. This far outstripped the...
Increased climate change awareness on a corporate level is leading to more investment – either direct or through funds – in start-ups that offer mitigation solutions. Asia is a key geography
Healthcare-focused Panacea Venture has led a $40 million Series C round for China’s XWPharma, a neurobiology-focused biotech developer previously known as XW Laboratories.
Kyee Technology, a Chinese digital medical platform has raised RMB430 million ($64 million) in a Series D round led by Tencent Holdings. Other investors include Longmen Capital, Dyee Capital and Royal Sea Capital.
Biocytogen, a Chinese contract research organization (CRO) that provides genetically-modified mice for drug testing, has raised RMB970 million ($143 million) in an extended tranche of Series D funding.